Candida infection and colonization among trauma patients

Virulence

Volumn 1, Issue 5, 2010, Pages 367-375

  Manolakaki, Dimitra ^a   Velmahos, George C ^a   Kourkoumpetis, Themistoklis ^b   Chang, Yuchiao ^c   Alam, Hasan B ^a   De Moya, Marc M ^a   Mylonakis, Eleftherios ^b  

^a Division of Trauma Emergency Surgery and Surgical Critical Care   (United States)

^b Division of Infectious Diseases Laboratory   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Candida; Candidiasis; Colonization; Intensive care; Trauma

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; GLUCOSE;

ABDOMINAL INFECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; CANDIDIASIS; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ECONOMIC ASPECT; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HOSPITAL CHARGE; HOSPITAL COST; HUMAN; INJURY SCALE; INTENSIVE CARE UNIT; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARENTERAL NUTRITION; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; UPPER GASTROINTESTINAL TRACT; WOUND INFECTION;

BACTERIA (MICROORGANISMS); CANDIDA;

EID: 78249265649     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.1.5.12796     Document Type: Article

References (22)

1. Toya SP, Schraufnagel DE, Tzelepis GE. Candiduria in intensive care units: association with heavy colonization and candidaemia. J Hosp Infect 2007; 66:201-6.
2. Safran DB, Dawson E. The effect of empiric and prophylactic treatment with fluconazole on yeast isolates in a surgical trauma intensive care unit. Arch Surg 1997; 132:1184-8.
3. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167:1247-51.
4. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-8.
5. Borzotta AP, Beardsley K. Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999; 134:657-64.
6. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149:2349-53.
7. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-35.
8. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33:1538-48.
9. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006; 34:646-52.
10. Peleg AY, Hoggan D, Mylonakis E. Medically important bacterial-fungal interaction. Nature Reviews Microbiology 2009; In press.
11. Kourkoumpetis T, Manolakaki D, Velmahos G, Chang Y, Alam H, De Moya M, et al. Candida infection and colonization among non-trauma emergency surgery patients. Virulence 2010; 1:362-9.
12. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33:177-86.
13. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality and contribution to total hospital deaths. Arch Intern Med 1995; 155:1177-84.
14. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702.
15. Ziegler TR. Parenteral nutrition in the critically ill patient. N Engl J Med 2009; 361:1088-97.
16. Hostetter MK. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990; 39:271-5.
17. Holley A, Dulhunty J, Blot S, Lipman J, Lobo S, Dancer C, et al. Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units. Int J Antimicrob Agents 2009; 33:5541-7.
18. Harris AD, Castro J, Sheppard DC, Carmeli Y, Samore MH. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin Infect Dis 1999; 29:926-8.
19. Goldacre MJ, Watt B, Loudon N, Milne LJ, Loudon JD, Vessey MP. Vaginal microbial flora in normal young women. Br Med J 1979; 1:1450-3.
20. Oriel JD, Waterworth PM. Effects of minocycline and tetracycline on the vaginal yeast flora. J Clin Pathol 1975; 28:403-6.
21. Miller LG, Hajjeh RA, Edwards JE Jr. Estimating the cost of nosocomial candidemia in the united states. Clin Infect Dis 2001; 32:1110.
22. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and metaanalysis. Intensive Care Med 2005; 31:1479-87.